EMERGINGDX INC — Department of Defense SBIR Phase II: PHASE II SBIR- RAPID, AUTOMATED, MULTIPLEXED OMICS PLATFORM
EMERGINGDX INC — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,299,987 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
EMERGINGDX INC received nearly $1.3 million from the Defense Health Agency for a Phase II SBIR project to build a rapid, automated system that analyzes multiple biological markers simultaneously. This platform could support faster health diagnostics and testing for military applications.
- Amount
- $1,299,987
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- MA
- Period
- 2025-09-26 → 2028-01-25
Technology domains
Description
PHASE II SBIR- RAPID, AUTOMATED, MULTIPLEXED OMICS PLATFORM